Sign in
4

Changes in Ownership

Trevi Therapeutics, Inc. Filed Acc 0001209191-23-018875

Chief Financial Officer sold 892 shares at $1.75 ($1,564)

  • Chief Financial Officer acquired 2,291 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Delfini Lisa · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-13 Exercise or conversion : show line 1 in the form +2,291 $0.51 $1,171 25,629 D
2023-03-13 Sale : show line 2 in the form −892 $1.75 $1,564 24,737 D
Open-market sales · 892 sh · avg $1.75 · $1,564

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-13 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −2,291 80,209 D
Loading xslF345X03/doc4.xml…